Sun Pharmaceutical Industries Ltd vs Sun Pharmaceutical Industries Ltd
A side-by-side comparison of Sun Pharmaceutical Industries Ltd (COVANCE) and Sun Pharmaceutical Industries Ltd (MIL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Sun Pharmaceutical Industries Ltd leads COVANCE vs MIL on 10 of 14 metrics (4 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation20
- Profitability40
- Growth10
- Size & financial health30
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
COVANCE takes 2/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
COVANCE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
COVANCE takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
COVANCE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.